Karolin Isaksson
1 – 10 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Desmoplastic melanoma in Sweden in 2009–2022 : A population-based registry study demonstrating distinctive tumour characteristics, incidence and survival trends
- Contribution to journal › Article
-
Mark
Modeling anti-tumor immune responses using patient-derived melanoma organoids
- Contribution to journal › Article
-
Mark
The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma
- Contribution to journal › Article
-
Mark
Evaluating COVID-19 Pandemic Impact on Melanoma Incidence and factors in Regions with Different Infection Control Strategies
(2026) In The British journal of dermatology
- Contribution to journal › Article
-
Mark
Comment on ‘Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma : a nationwide population-based registry study from Sweden’: reply from the authors
- Contribution to journal › Letter
-
Mark
Interplay between AIB1 genotypes and radiotherapy in a Swedish population-based breast cancer cohort
- Contribution to journal › Article
-
Mark
Characteristics and overall survival in patients with T1 melanoma : A nationwide matched cohort study
- Contribution to journal › Article
-
Mark
Five-year survival after introduction of adjuvant treatment in stage III melanoma : A nationwide registry-based study
- Contribution to journal › Article
-
Mark
SWE-NEO : Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial
- Contribution to journal › Letter
-
Mark
Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma : A Nationwide Population-Based Registry Study from Sweden
- Contribution to journal › Article
